Key result
Angiotensin II induces lipid peroxidation and modification of cellular molecules in human endothelial cells, which is mediated by the AT1 receptor and inhibited by losartan.
Why the study?
Ang II stimulates ROS formation and lipid peroxidation, but its role in inducing lipid peroxidation-derived cellular modifications in human endothelial cells remained to be characterized.
Angiotensin II induces lipid peroxidation and modification of cellular molecules via AT1 receptor activation, suggesting a mechanism for Ang II-mediated cardiovascular dysfunction.
Answers are grounded in this paper and cite their sources.
ONE/HNE modifications alter Ang II activity; leaves open contribution to oxidative cardiovascular signaling in vivo.
Angiotensin (Ang) II is a major bioactive peptide of the renin/angiotensin system and is involved in various cardiovascular functions and diseases. Ang II type 1 (AT 1 ) receptor mediates most of the physiological effects of Ang II. Previous studies have revealed that the lipid peroxidation products 4-oxo-2( E )-nonenal (ONE) and 4-hydroxy-2( E )-nonenal (HNE) readily modify the N-terminus and Asp 1, Arg 2, and His 6 residues of Ang II, and these modifications alter the biological activities of Ang II. Ang II is known to stimulate the formation of reactive oxygen species (ROS) that mediate cardiovascular remodeling. Another major consequence of ROS-derived damage is lipid peroxidation, which generates genotoxic aldehydes such as ONE and HNE. This study demonstrated that Ang II induced lipid peroxidation-derived modifications of cellular molecules in EA.hy926 cells, a human vascular endothelial cell line. Ang P (ONE- and ROS-derived N-terminal pyruvamide Ang II) and [His 6 (HNE)]-Ang II were detected in the medium of EA.hy926 cells incubated with Ang II, and their concentrations increased dose-dependently upon the addition of ascorbic acid (AscA) and CuSO 4 . Cells were then subjected to metabolic labeling using SILFAC ( s table i sotope l abeling by f atty a cids in c ell culture) with [ 13 C 18 ]-linoleic acid. Analysis of cellular phospholipids indicated over 90% labeling. [ 13 C 9 ]-Thiadiazabicyclo-ONE-glutathione adduct as well as Ang P and [His 6 ([ 13 C 9 ]-HNE)]-Ang II was detected in the labeled cells upon treatment with Ang II and their concentrations increased in an Ang II dose-dependent manner. Incubation of the labeled cells with losartan, an AT 1 receptor blocker, inhibited the formation of modified Ang IIs in a dose-dependent manner. These results indicate that Ang II induces lipid peroxidation and modification of various cellular molecules and these reactions are mediated by the activation of AT 1 receptor. Therefore, lipid peroxidation could be one mechanism by which Ang II contributes to cardiovascular dysfunction.
No takes yet. Share an insight, caveat, or question.
Lee et al. (2019) studied this question. Angiotensin II vs. Losartan was evaluated on Formation of modified Ang IIs and lipid peroxidation. Angiotensin II induces lipid peroxidation and modification of cellular molecules in human endothelial cells, which is mediated by the AT1 receptor and inhibited by losartan.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: